Susan A. Knudson
2016 - Neothetics
In 2016, Susan A. Knudson earned a total compensation of $360.4K as Former Chief Financial Officer at Neothetics, a 13% decrease compared to previous year.
Compensation breakdown
Bonus | $59,052 |
---|---|
Option Awards | $19,170 |
Salary | $281,197 |
Other | $1,010 |
Total | $360,429 |
Knudson received $281.2K in salary, accounting for 78% of the total pay in 2016.
Knudson also received $59.1K in bonus, $19.2K in option awards and $1K in other compensation.
Rankings
In 2016, Susan A. Knudson's compensation ranked 12,227th out of 14,075 executives tracked by ExecPay. In other words, Knudson earned more than 13.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,227 | 13th |
Manufacturing | 4,791 | 13th |
Chemicals And Allied Products | 1,707 | 10th |
Drugs | 1,386 | 10th |
Pharmaceutical Preparations | 1,071 | 9th |
Knudson's colleagues
We found five more compensation records of executives who worked with Susan A. Knudson at Neothetics in 2016.
2016
Saundra Pelletier
Neothetics
Chief Executive Officer
2016
Justin File
Neothetics
Chief Financial Officer
2016
Kelly Culwell
Neothetics
Chief Medical Officer
2016
George Mahaffey
Neothetics
Chief Executive Officer
2016
Maria Feldman
Neothetics
Former Vice President, Clinical Research, Operations, Regulatory and Quality
News
Conatus Pharmaceuticals CFO Susan Knudson's 2022 pay jumps 26% to $681K
May 1, 2023
Conatus Pharmaceuticals CEO Steven Mento's 2020 pay slips 5% to $1.3M
April 15, 2021
Pfenex CEO Evert Schimmelpennink's 2019 pay rises 11% to $1.8M
April 1, 2020
Neothetics CEO Saundra Pelletier's 2018 pay jumps 401% to $8.3M
April 24, 2019
Pfenex CEO Evert Schimmelpennink's 2018 pay jumps 47% to $1.6M
April 4, 2019